Lluís Ramió i Torrentà

Firma: Lluís Ramió i Torrentà

Jornades Gironines del Mediterrani en Esclerosi Múltiple

Jornades Gironines del Mediterrani en Esclerosi Múltiple

Català
Llegir mes

Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses

Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses

Our aim was to investigate differences in immune mechanisms in multiple sclerosis (MS) relapse, after high-dose oral methylprednisolone (oMP) or intravenous methylprednisolone (ivMP). We measured serum cytokines (IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α and IFN-γ) in 39 of 49 MS patients with moderate-severe relapse, whom were treated with ivMP or oMP in a placebo-controlled, non-inferiority clinical trial. We assessed these cytokine levels at baseline and at 1 and 4 weeks post-treatment.

Undefined
Llegir mes

A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis

A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis

BACKGROUND:

MS-Line! was created to provide an effective treatment for cognitive impairment in multiple sclerosis (MS) patients.

Undefined
Llegir mes
Subscriure a Lluís Ramió i Torrentà